The Effect of Natural-Based Formulation (NBF) on the Response of RAW264.7 Macrophages to LPS as an In Vitro Model of Inflammation

Keyphrases

• Inflammation 100%
• In Vitro Model 100%
• RAW264.7 Macrophages 100%
• Lipopolysaccharide 100%
• Inflammatory Markers 66%
• Chronic Inflammatory Diseases 66%
• Infectious Diseases 33%
• Interleukin-6 33%
• Inflammatory Cytokines 33%
• MRNA Level 33%
• Macrophages 33%
• Interleukin-1β 33%
• Chemokines 33%
• Tumor Necrosis Factor-α 33%
• Viral Infection 33%
• Inflammatory Bowel Disease 33%
• NF-B 33%
• Toxic Effects 33%
• Nitrite 33%
• Immune Cells 33%
• Hepatitis 33%
• Lactate Dehydrogenase Release 33%
• Foreign Body 33%
• Asthma 33%
• Tuberculosis 33%
• Serious Condition 33%
• Acute Inflammatory Diseases 33%
• Anti-inflammatory Effect 33%
• Prolonged Inflammation 33%
• Toll-like Receptor 2 (TLR2) 33%
• Cyclooxygenase-2 33%
• Inflammatory Immune Response 33%
• Bloodstream 33%
• Immunomodulatory Effect 33%
• Toll-like Receptor 4 (TLR4) 33%
• Sinusitis 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammation 100%
• Lipopolysaccharide 100%
• Inflammatory Disease 66%
• Interleukin 6 33%
• Tumor Necrosis Factor 33%
• Anti-Inflammatory Drug 33%
• Toxicity 33%
• Chemokine 33%
• Nitrite 33%
• Inflammatory Bowel Disease 33%
• Virus Infection 33%
• Cytokine 33%
• Lactate Dehydrogenase 33%
• Toll Like Receptor 2 33%
• Sinusitis 33%
• Foreign Body 33%
• Asthma 33%
• Toll Like Receptor 4 33%
• Messenger RNA 33%

Immunology and Microbiology

• Macrophage 100%
• Inflammatory Disorder 66%
• Interleukin 6 33%
• Interleukin-1 33%
• Chemokine 33%
• Immune Response 33%
• Proinflammatory Cytokine 33%
• Viral Disease 33%
• Tumor Necrosis Factor Alpha 33%
• Immunocompetent Cell 33%
• Sinusitis 33%
• Inflammatory Bowel Disease 33%
• TLR4 33%
• Blood Flow 33%
• Asthma 33%
• TLR2 33%